Technical Analysis for GAGXF - Agennix Ag

Grade Last Price % Change Price Change
grade F 0.0001 -99.71% -0.0349
GAGXF closed down 99.71 percent on Tuesday, June 4, 2019, on 2 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Down
See historical GAGXF trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Pocket Pivot Bullish Swing Setup -99.71%
Narrow Range Bar Range Contraction -99.71%
Stochastic Reached Oversold Weakness -99.71%
Wide Bands Range Expansion -99.71%

Older signals for GAGXF ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Agennix AG is a publicly listed biopharmaceutical company that is focused on the development of novel therapies that have the potential to substantially improve the length and quality of life of critically ill patients in areas of major unmet medical need. The Company's most advanced program is talactoferrin, an oral immunotherapy that has demonstrated activity in randomized, double-blind, placebo-controlled Phase II studies in non-small cell lung cancer and in severe sepsis. Talactoferrin is currently in Phase III clinical trials in non-small cell lung cancer, and a Phase II/III trial with talactoferrin in severe sepsis is underway. Other clinical development programs include RGB-286638, a multi-targeted kinase inhibitor in Phase I testing, and a topical gel form of talactoferrin for diabetic foot ulcers. Agennix's registered seat is in Heidelberg, Germany. The Company has three sites of operation: Planegg/Munich, Germany; Princeton, New Jersey and Houston, Texas.
Biopharmaceutical Immunotherapy Non Small Cell Lung Cancer Diabetic Foot Ulcers Pyrrolidines Bemcentinib
Is GAGXF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.22
52 Week Low 0.0001
Average Volume 54,358
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0655
10-Day Moving Average 0.0697
Average True Range 0.0416
ADX 8.11
+DI 46.54
-DI 57.6434
Chandelier Exit (Long, 3 ATRs ) 0.0952
Chandelier Exit (Short, 3 ATRs ) 0.1249
Upper Bollinger Band 0.1617
Lower Bollinger Band -0.0307
Percent B (%b) 0.16
BandWidth 293.740458
MACD Line -0.0133
MACD Signal Line -0.01
MACD Histogram -0.0033
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0001
Resistance 3 (R3) 0.0001 0.0001 0.0001
Resistance 2 (R2) 0.0001 0.0001 0.0001 0.0001
Resistance 1 (R1) 0.0001 0.0001 0.0001 0.0001 0.0001
Pivot Point 0.0001 0.0001 0.0001 0.0001 0.0001
Support 1 (S1) 0.0001 0.0001 0.0001 0.0001 0.0001
Support 2 (S2) 0.0001 0.0001 0.0001 0.0001
Support 3 (S3) 0.0001 0.0001 0.0001
Support 4 (S4) 0.0001